CN103652061A - Compound lipid-lowering tea - Google Patents
Compound lipid-lowering tea Download PDFInfo
- Publication number
- CN103652061A CN103652061A CN201310670723.8A CN201310670723A CN103652061A CN 103652061 A CN103652061 A CN 103652061A CN 201310670723 A CN201310670723 A CN 201310670723A CN 103652061 A CN103652061 A CN 103652061A
- Authority
- CN
- China
- Prior art keywords
- tea
- lowering
- compound
- seed
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of healthcare tea and particularly relates to compound lipid-lowering tea. The compound lipid-lowering tea is prepared from the following components by weight: 10g-15g of medlar, 5g-8g of fleece-flower root, 8g-13g of solomonseal rhizome, 10g-15g of cassia occidentalis, 10g-15g of parasitic loranthus, 6g-10g of semen raphani, 3g-5g of pear seeds and 15g-20g of green tea. According to the technical scheme provided by the invention, the components are integrated to achieve a synergetic effect, and the compound lipid-lowering tea disclosed by the invention not only can be used for activating blood circulation to dissipate stasis, activating qi and eliminating phlegm, but also can achieve the effects of enriching the blood, strengthening kidneys and lowering lipid.
Description
Technical field:
The invention belongs to health tea technique field, relate in particular to a kind of compound antihyperglycemic tea.
Background technology
Hyperlipidemia can be divided into primary and Secondary cases two classes.Primary is with congenital and hereditary relevant, due to single-gene defect or polygenes defect, make to participate in acceptor, enzyme or the apolipoprotein caused by abnormal of lipoprotein transhipment and metabolism, or due to environmental factor (diet, nutrition, medicine) with cause by unknown mechanism.Secondary cases is multiple is born in metabolic disorders (diabetes, hypertension, myxoedema, hypothyroidism, obesity, liver and kidney disease, adrenal cortex function are hyperfunction), or with other factor ages, sex, season, drink, smoking, diet, physical exertion, stress, emotional activity etc. is relevant.The clinical manifestation of hyperlipidemia is mainly that lipid deposits caused xanthoma in corium and lipid deposits caused artery sclerosis at blood vessel endothelium.Although hyperlipidemia can cause xanthoma, its incidence is also not bery high; And atherosclerotic generation and development are a kind of slowly progressive processes.Therefore most of patients non-evident sympton and abnormal sign under normal conditions.Many people just find that there is blood plasma lipoprotein level while carrying out blood biochemical check due to other reasons to raise.
But for high fat of blood patient, western medicine has more toxic and side effect, and to using treatment by Chinese herbs, conventionally decoct medicinal herbs and be the thing wasting time very much, therefore can there is a kind of tea-drinking that can substitute Chinese medicine, not only overcome above-mentioned defect, can also play the effect of lipopenicillinase.
Summary of the invention
The object of the invention is to overcome above-mentioned technical defect, a kind of tea-drinking that is convenient for carrying and possesses said function is provided.
A compound antihyperglycemic tea, is prepared from by following component: matrimony vine 10-15g
Tuber of multiflower knotweed 5-8g sealwort 8-13g Cassia occidentalis 10-15g parasitic loranthus 10-15g
Radish seed 6-10g pears seed 3-5g green tea 15-20g.
Compound antihyperglycemic tea, is preferably prepared from by following component: matrimony vine 10g tuber of multiflower knotweed 5g sealwort 8g Cassia occidentalis 10g parasitic loranthus 10g radish seed 6-10g pears seed 3g green tea 15g.
Compound antihyperglycemic tea, is preferably prepared from by following component: matrimony vine 15g tuber of multiflower knotweed 8g sealwort 13g Cassia occidentalis 15g parasitic loranthus 15g radish seed 6-10g pears seed 5g green tea 20g.
Compound antihyperglycemic tea, is preferably prepared from by following component: matrimony vine 13g tuber of multiflower knotweed 7g sealwort 10g Cassia occidentalis 13g parasitic loranthus 13g radish seed 8g pears seed 4g green tea 18g.
By above-mentioned component feeding, use hot water injection one time, put into cup, by the brewed in hot water of 60-80 degree.Every two days potions one month are a course for the treatment of.
Beneficial effect of the present invention
Technical scheme of the present invention, integrates said components, plays collaborative effect, not only can activate blood circulation and disperse blood clots, and sharp gas eliminates the phlegm, and can also play and enrich blood, strong kidney, the effect of lipopenicillinase.
The specific embodiment
Below by specific embodiment, further illustrate technical scheme of the present invention, but content of the present invention is not limited with specific embodiment.
Embodiment 1
A compound antihyperglycemic tea, is prepared from by following component: matrimony vine 10g tuber of multiflower knotweed 5g sealwort 8g Cassia occidentalis 10g parasitic loranthus 10g radish seed 6-10g pears seed 3g green tea 15g.
Embodiment 2
A compound antihyperglycemic tea, is prepared from by following component: matrimony vine 15g tuber of multiflower knotweed 8g sealwort 13g Cassia occidentalis 15g parasitic loranthus 15g radish seed 6-10g pears seed 5g green tea 20g.
Embodiment 3
A compound antihyperglycemic tea, is prepared from by following component: matrimony vine 13g tuber of multiflower knotweed 7g sealwort 10g Cassia occidentalis 13g parasitic loranthus 13g radish seed 8g pears seed 4g green tea 18g.
Claims (4)
1. a compound antihyperglycemic tea, is characterized in that: by following component, be prepared from: matrimony vine 10-15g
Tuber of multiflower knotweed 5-8g sealwort 8-13g Cassia occidentalis 10-15g parasitic loranthus 10-15g
Radish seed 6-10g pears seed 3-5g green tea 15-20g.
2. compound antihyperglycemic tea as claimed in claim 1, is characterized in that: by following component, be prepared from: matrimony vine 10g tuber of multiflower knotweed 5g sealwort 8g Cassia occidentalis 10g parasitic loranthus 10g radish seed 6-10g pears seed 3g green tea 15g.
3. compound antihyperglycemic tea as claimed in claim 1, is characterized in that: by following component, be prepared from: matrimony vine 15g tuber of multiflower knotweed 8g sealwort 13g Cassia occidentalis 15g parasitic loranthus 15g radish seed 6-10g pears seed 5g green tea 20g.
4. compound antihyperglycemic tea as claimed in claim 1, is characterized in that: by following component, be prepared from: matrimony vine 13g tuber of multiflower knotweed 7g sealwort 10g Cassia occidentalis 13g parasitic loranthus 13g radish seed 8g pears seed 4g green tea 18g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310670723.8A CN103652061A (en) | 2013-12-11 | 2013-12-11 | Compound lipid-lowering tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310670723.8A CN103652061A (en) | 2013-12-11 | 2013-12-11 | Compound lipid-lowering tea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103652061A true CN103652061A (en) | 2014-03-26 |
Family
ID=50291779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310670723.8A Pending CN103652061A (en) | 2013-12-11 | 2013-12-11 | Compound lipid-lowering tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103652061A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1067179A (en) * | 1992-06-17 | 1992-12-23 | 吴守仓 | A kind of prescription of hypolipidemic |
| CN101683467A (en) * | 2008-09-22 | 2010-03-31 | 赵春 | Preparation method of tea for reducing blood fat |
| CN101721563A (en) * | 2009-11-09 | 2010-06-09 | 徐兆云 | Three high rehabilitation tea |
| CN102335339A (en) * | 2011-10-19 | 2012-02-01 | 成都绿迪科技有限公司 | Traditional Chinese medicine preparation for treating hyperlipemia |
| CN102423413A (en) * | 2012-01-04 | 2012-04-25 | 陈伯明 | Medicament for treating hyperlipemia and fatty liver and preventing atherosclerosis as well as applications thereof |
| CN102579872A (en) * | 2012-03-05 | 2012-07-18 | 姜吉双 | Medical composition with weight reducing function |
-
2013
- 2013-12-11 CN CN201310670723.8A patent/CN103652061A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1067179A (en) * | 1992-06-17 | 1992-12-23 | 吴守仓 | A kind of prescription of hypolipidemic |
| CN101683467A (en) * | 2008-09-22 | 2010-03-31 | 赵春 | Preparation method of tea for reducing blood fat |
| CN101721563A (en) * | 2009-11-09 | 2010-06-09 | 徐兆云 | Three high rehabilitation tea |
| CN102335339A (en) * | 2011-10-19 | 2012-02-01 | 成都绿迪科技有限公司 | Traditional Chinese medicine preparation for treating hyperlipemia |
| CN102423413A (en) * | 2012-01-04 | 2012-04-25 | 陈伯明 | Medicament for treating hyperlipemia and fatty liver and preventing atherosclerosis as well as applications thereof |
| CN102579872A (en) * | 2012-03-05 | 2012-07-18 | 姜吉双 | Medical composition with weight reducing function |
Non-Patent Citations (2)
| Title |
|---|
| 刘慧: "梨籽能降胆固醇", 《老同志之友》 * |
| 苏孝共等: "降脂中药的性效辨析及机理探讨", 《中医药学刊》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ulbricht et al. | An evidence-based systematic review of tongkat ali (Eurycoma longifolia) by the natural standard research collaboration | |
| CN103627559B (en) | A kind of Antilipemic beverage | |
| CN106924615A (en) | Reducing blood lipid slim tea | |
| Zhu et al. | Pharmaceutical potential of high-altitude plants for fatigue-related disorders: A review | |
| JP6140789B2 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NON-ALCOHOLIC FATTY LIVER PATIENT CONTAINING REINFORCED CONCENTRATE ENHANCED COMPOUND K COMPOUND AND HEALTH FUNCTIONAL FOOD | |
| Chen et al. | Study on effects of Zhi Zi (Fructus gardeniae) on non-alcoholic fatty liver disease in the rat | |
| Huang et al. | Clinical evidence and potential mechanisms of complementary treatment of ling gui zhu gan formula for the management of serum lipids and obesity | |
| CN103652061A (en) | Compound lipid-lowering tea | |
| Omar et al. | Hepatoprotective and antidiabetic effects of apple cider vinegar (a prophetic medicine remedy) on the liver of male rats | |
| CN103704407A (en) | Compound lipid-decreasing and health-protection tea | |
| CN105028788A (en) | Tea capable of removing liver fire and improving eyesight | |
| Gómez et al. | Eryngium heterophyllum and Amphipterygium adstringens Tea Effect on Triglyceride Levels: A Clinical Trial | |
| Kim et al. | Antiatherogenic and antioxidative effects of Houttuynia cordata extracts in rats fed a high-fat diet | |
| CN106924481A (en) | Anti-senility hypolipemic health liquor | |
| CN104000210A (en) | Lipid-lowering food additive | |
| CN106074984A (en) | A kind of the root bark of persimmon tree medicine drink and its preparation method and application | |
| CN105454757A (en) | Dietotherapy formula suitable for diabetic patients | |
| Su-Hong et al. | Therapeutic effect of petroleum ether extract from Semen cuscutae against β-estradiol 3-benzoate induced kidney-yang deficiency in mice | |
| CN106922896A (en) | A kind of blood fat reducing tea | |
| SHANAN | ERGOGENIC AND METABOLITES ANALYSES OF PIYAROM DATE (Phoenix dactylifera L.) USING NMR-BASED METABOLOMICS AND ITS EFFECT ON SPRAGUE DAWLEY RATS | |
| CN106929346A (en) | Antilipemic healthy wine | |
| Mukonowenzou | The effects of ursolic acid on neonatal programming and its potential to prevent the development of metabolic dysfunction in sprague dawley rats | |
| Lee et al. | The Management of Metabolically Unhealthy Obesity. | |
| CN104825659A (en) | Liupao tea containing composition with blood fat reducing function | |
| Đekić-Ivanković et al. | The effects of a new plant mixture on lipid levels in patients with metabolic syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140326 |